FOR IMMEDIATE RELEASE
Physician and Mayo Clinic family member joins HNT's investor group alongside go-to-market advisor Terry Lee, as the inhalable nutraceutical platform scales
ASHEVILLE, N.C. – August 6, 2026 – HaloNutraTherapy Systems, Inc. ("HNT"), maker of the patented inhalable nutraceutical platform, today announced it has closed a seed funding round from a group of investors, including Dr. Andrew Mayo and Terry Lee. The round will support manufacturing scale-up, marketing, and continued development of HNT's pipeline of inhalable wellness formulations.
"We're grateful to welcome a group of investors who bring not just capital, but real expertise and credibility to HNT," said Jeff Braile, Co-Founder and CEO of HaloNutraTherapy. "Dr. Mayo and Terry each add something distinct – clinical insight into compound formulation and go-to-market firepower to help us scale into new channels."
Dr. Andrew Mayo Joins as Seed Investor and Formulation Collaborator
HaloNutraTherapy is pleased to announce that Dr. Andrew Mayo has joined as a seed investor. In addition, Dr. Mayo will collaborate with HNT on compound formulations.
Dr. Mayo's interest in the potential of non-pharmaceutical compounds is rooted in his family's long history in medicine, including its deep ties to the Mayo Clinic – a heritage that shaped his belief that these compounds could eventually play a role in treating disease.
Dr. Mayo serves as Chief Medical Officer for St. Croix Hospice, a role he has held since 2014 after joining the organization in 2012. He focuses his time on collaborating with clinical colleagues, patients and caregivers, and outside healthcare partners to ensure patients receive high-quality, medically advanced, compassionate end-of-life care that meets their needs and wishes.
A native of Minnesota, Dr. Mayo was inspired to pursue a career in medicine by his family's long history of dedication to community healthcare and innovation. After completing his family practice residency at Bethesda Hospital in St. Paul, Minnesota, Dr. Mayo spent 17 years practicing in St. Croix Falls, Wisconsin, as a family medicine physician, providing full-spectrum care in emergency medicine, inpatient hospital, outpatient clinic, and obstetrics settings.
Dr. Mayo has served on clinical and hospital leadership boards and as Medical Director for several nursing homes. In 2023, he was recognized as one of Becker's Hospital Review's "110 CMOs to Know." He received his undergraduate degree from St. Olaf College in Northfield, Minnesota, and studied medicine at the University of Minnesota – Duluth. He continues to pursue additional medical training and holds a Hospice Medical Director Certification.
Terry Lee Joins as Advisor and Seed Investor
HaloNutraTherapy is also pleased to announce that Terry Lee has joined as an advisor and as part of the company's seed investor group. Terry has supported HNT on revenue strategy and go-to-market since early on, and formalizes that relationship with this dual advisor and investor role.
Terry has a lifelong passion for fitness and improving healthspan. He has completed 10 marathons and 6 Spartan Races, climbed Mt. Rainier, and continues to compete in Ultimate Frisbee. He is the founder of Second Peak, a community and newsletter for men over 50 who want to stay fit, relevant, and engaged in an ever-changing world – covering healthspan and fitness, emerging technology, and opportunities in advisory roles and angel investing.
Terry brings more than 20 years of experience building revenue engines for B2B SaaS companies from seed stage through public markets, with deep specialization in regulated industries including financial services, legal, insurance, and healthcare. He has scaled ARR from $1M to over $20M, managed sales teams delivering over $100M in ARR, and led revenue teams of 1 to 100 across sales, marketing, demand generation, and customer success. Alongside his operating work, Terry advises a portfolio of high-growth companies on go-to-market strategy, including Fuse, Cadre, and HaloNutraTherapy.
About HaloNutraTherapy
HaloNutraTherapy is the world's first patented inhalable wellness platform, combining pharmaceutical-grade salt with high-purity nutraceuticals and peptides. Its NutraPocket™ device delivers a gentle mist that carries nutrients directly into the bloodstream through the lungs while providing the respiratory benefits of pharmaceutical salt. In addition to the NutraPocket, the compounds are also available through the most popular industry Halotherapy products like the HaloRed Booth, the HaloSauna and the HaloFLEX. HNT's current formulations include Halo NAD+, Halo NAD+ & Glutathione, HaloRecovery, and HaloRelax, with additional formulations for perimenopause, sleep, memory, and bone health in development. HNT's first U.S. commercial partner, Carillon Miami Wellness Resort, launched in May 2026. HNT is also working with existing nutraceutical companies for them to create their own custom compounds with the ability to also co-brand the NutraPocket device, if desired.
For more information, visit halonutratherapy.com.
Media Contact
Jeff Braile, Co-Founder & CEO
HaloNutraTherapy Systems, Inc.
jeff@halonutratherapy.com
This announcement is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities.